Lupaneta Pack
NDC Package 0074-1052-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Lupaneta Pack is this product contains 2 medications: leuprolide and norethindrone. Marketed by Abbvie Inc., this product is identified by NDC 0074-1052 and is authorized under FDA application NDA203696.

Identification & Billing

NDC Package Code
0074-1052-10
Package Description
1 KIT in 1 CARTON * 30 TABLET in 1 BOTTLE (0074-1049-02) * 1 mL in 1 SYRINGE * 1 mL in 1 PACKET
Product Code
0074-1052
11-Digit Billing Format
00074105210

Clinical Specifications

Proprietary Name
Lupaneta Pack
Dosage Form
-
Usage Information
This product contains 2 medications: leuprolide and norethindrone. Leuprolide is used to treat pain due to a certain uterus disorder (endometriosis). It works by shrinking the abnormal uterine tissue that causes the pain. Uterine tissue needs the female hormone estrogen to grow and spread. Leuprolide helps to decrease the amount of estrogen that is made in the body. Norethindrone helps to decrease the bone thinning effect of leuprolide. Norethindrone is a type of female hormone (progestin). It is like the hormone progesterone that your body makes naturally.

Regulatory & Marketing

Labeler Name
Abbvie Inc.
FDA Application #
NDA203696
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-01-2013
End Marketing Date
10-31-2021
Listing Expiration
10-31-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0074-1052). Click a package code to view its specific billing and regulatory data.

0074-1052-05
1 KIT in 1 CARTON * 30 TABLET in 1 BOTTLE (0074-1049-02) * 1 mL in 1 SYRINGE * 1 mL in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0074-1052-10 identifies a specific commercial package of 1 kit in 1 carton * 30 tablet in 1 bottle (0074-1049-02) * 1 ml in 1 syringe * 1 ml in 1 packet of Lupaneta Pack, labeled by Abbvie Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Abbvie Inc. on July 01, 2013. The current certification is valid through October 31, 2021.

What are the primary indications for this medication?

This product contains 2 medications: leuprolide and norethindrone. Leuprolide is used to treat pain due to a certain uterus disorder (endometriosis). It works by shrinking the abnormal uterine tissue that causes the pain. Uterine tissue needs the female hormone estrogen to grow and spread. Leuprolide helps to decrease the amount of estrogen that is made in the body. Norethindrone helps to decrease the bone thinning effect of leuprolide. Norethindrone is a type of female hormone (progestin). It is like the hormone progesterone that your body makes naturally.

How is this Abbvie Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00074105210. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0074-1052-10
11-Digit CMS (5-4-2)
00074-1052-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.